Release Date: 01/12/21 18:53 Summary: Resignation of Company Secretary Price Sensitive: No Download Document 95.78KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%